Metviron Trio 1 Tablet ER
Metviron Trio 1 Tablet ER
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹20
that's 39% off!
About This Medicine
Product description & overview
Metviron Trio 1 Tablet ER is a fixed-dose combination product containing glimepiride (1mg), metformin (500mg), and voglibose (0.2mg) designed to treat type 2 diabetes mellitus. This oral antihyperglycemic agent is intended for once-daily administration. Glimepiride, a sulfonylurea, stimulates insulin secretion and enhances glucose-dependent insulin secretion, while metformin, a biguanide, reduces glucose absorption in the small intestine and increases glucose uptake in the periphery. Voglibose, a synthetic α-glucosidase inhibitor, delays carbohydrate digestion and absorption. The combination of these three agents provides a synergistic effect in controlling hyperglycemia. Metviron Trio 1 Tablet ER is available in a once-daily extended-release formulation, allowing for more consistent blood glucose control throughout the day. This product is contraindicated in patients with type 1 diabetes, patients with a history of serious hypersensitivity reactions, and in those with liver disease or kidney impairment. As with all medications, patients should be closely monitored for signs of hypoglycemia, hyperglycemia, and other adverse effects.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Metviron Trio 1 Tablet ER.
High Risk
Pregnancy
Metviron Trio 1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Metviron Trio 1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Metviron Trio 1 Tablet ER may be needed. Please consult your doctor. Metviron Trio 1 Tablet ER is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Metviron Trio 1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Metviron Trio 1 Tablet ER is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Metviron Trio 1 Tablet ER is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Metviron Trio 1 Tablet ER
Products matching your search
Glimicer 1mg Tablet
Glimicer 1mg Tablet
Glyciphage-PG 1 Tablet SR
Glyciphage-PG 1 Tablet SR
Glimser Forte 1 Tablet PR
Glimser Forte 1 Tablet PR
Justmet Safe 2 Tablet ER
Justmet Safe 2 Tablet ER
Glucut 2 MT Tablet
Glucut 2 MT Tablet
WE-Sita M Tablet
WE-Sita M Tablet
WE-Sita 50 Tablet
WE-Sita 50 Tablet
Glized-M Tablet PR